Specialized Consultation
A deep review of personal and family history of thrombosis or pregnancy loss with Dr. Ghilezan Florica.
Clinical Haematology
Optimising Blood Health for Pregnancy Success
Clinical haematology at Gynatal Clinic (Timișoara) focuses on managing blood-clotting disorders, such as thrombophilia, and immune factors that cause implantation failure or recurrent miscarriages. Led by Dr. Ghilezan Florica, we provide specialized screening for thrombophilia, offering personalized anticoagulant protocols to ensure optimal uterine blood flow and fetal development.
Why Haematology Matters in IVF and Pregnancy
Fertility is not just about embryos; it is about the "soil" – the uterine environment. Proper blood circulation in the uterine lining is vital for an embryo to implant and receive nutrients. If the blood is prone to excessive clotting (thrombophilia), micro-clots can form, blocking the embryo’s nutrition and leading to a negative pregnancy test or early loss.
Conditions We Treat: Managing the "Invisible" Barriers
Our haematology department integrates seamlessly with our IVF protocols to address:
- Hereditary & Acquired Thrombophilia: Screening for genetic mutations like Factor V Leiden, Prothrombin G20210A, and Antiphospholipid Syndrome (APS).
- Recurrent pregnancy loss – assessing whether coagulation disorders or APS may contribute to recurrent miscariiage as part of a comprehensive evaluation
- Recurrent Implantation Failure (RIF): Investigating if blood flow issues are preventing high-quality embryos from attaching.
- Iron deficiency and Anemia: Correcting iron or B12 deficiencies to optimize egg quality and maternal health before the retrieval process.
- Immune-Related Haematological Issues: Addressing autoimmune responses that target placental cells.
The Gynatal Haematology Roadmap
To reduce "Cognitive Friction" and provide clarity, we follow a structured diagnostic pathway:
Advanced Laboratory Screening
Precise testing for thrombophilia profiles, D-Dimers, and coagulation parameters (APTT, Quick time).
Personalized Anticoagulant Strategy
Individualized dosing of low-molecular-weight heparin (LMWH) and antiplatelet therapy based on the patient's weight and transfer timing.
Biological Monitoring
Ongoing blood tests throughout the first trimester to adjust medication as the pregnancy progresses.